Coagulation Activation – Process and Significance
Coagulation activation is the process by which blood clots at the site of a vessel injury to stop bleeding. It is a vital, tightly regulated defence mechanism of the body.
Wissenswertes über "Coagulation Activation"
Coagulation activation is the process by which blood clots at the site of a vessel injury to stop bleeding. It is a vital, tightly regulated defence mechanism of the body.
What is Coagulation Activation?
Coagulation activation refers to the biological process by which blood transforms from a liquid into a solid clot following injury to a blood vessel. This process is part of haemostasis -- the body mechanism for stopping bleeding -- and involves a carefully orchestrated interplay between platelets, coagulation factors, and plasma proteins.
Stages of Coagulation Activation
Primary Haemostasis
Immediately after a vessel is injured, the blood vessel constricts (vasoconstriction) to reduce blood flow. Platelets then adhere to the exposed vessel wall and aggregate to form an initial, unstable platelet plug. This step is facilitated by the von Willebrand factor, a protein that acts as a bridge between platelets and the damaged vessel surface.
Secondary Haemostasis (Coagulation Cascade)
The secondary phase involves the activation of the coagulation cascade, a series of reactions in which clotting factors sequentially activate one another. There are two main pathways:
- Extrinsic Pathway (Tissue Factor Pathway): Triggered by tissue factor (TF) released from damaged tissue at the site of injury.
- Intrinsic Pathway (Contact Activation): Activated when blood comes into contact with foreign surfaces or altered vessel structures.
Both pathways converge into a common pathway that generates thrombin. Thrombin converts the soluble plasma protein fibrinogen into insoluble fibrin. Fibrin forms a mesh that reinforces the platelet plug into a stable, firm blood clot (thrombus).
Fibrinolysis
Once healing has occurred, the clot is gradually dissolved through a process called fibrinolysis. The enzyme plasmin breaks down the fibrin network, restoring normal blood flow through the vessel.
Causes of Altered Coagulation Activation
Coagulation activation can be either excessive or insufficient:
- Excessive coagulation (thrombophilia): Genetic mutations (e.g., Factor V Leiden), prolonged immobility, surgery, certain medications, or systemic illnesses can increase clotting activity and raise the risk of thrombosis.
- Insufficient coagulation (haemophilia, clotting deficiencies): Absent or reduced clotting factors (e.g., in haemophilia A or B) or low platelet counts can lead to an increased tendency to bleed.
Clinical Relevance
Disturbances in coagulation activation can be life-threatening. Key conditions include:
- Deep vein thrombosis (DVT)
- Pulmonary embolism
- Heart attack and stroke (caused by arterial thrombus formation)
- Disseminated intravascular coagulation (DIC): a severe disorder in which the entire clotting system is activated uncontrollably throughout the body
- Haemophilia and other inherited bleeding disorders
Diagnosis
Several laboratory tests are available to assess coagulation activation:
- Prothrombin time (PT) / INR: Evaluates the extrinsic coagulation pathway
- aPTT (activated partial thromboplastin time): Evaluates the intrinsic coagulation pathway
- Platelet count: Assesses the number of platelets available for clot formation
- D-dimers: Elevated levels indicate increased clotting activity and fibrinolysis
- Individual clotting factor assays: e.g., Factor VIII in suspected haemophilia A
Treatment
Treatment depends on the type of coagulation disorder:
- Anticoagulants (e.g., heparin, warfarin, direct oral anticoagulants such as rivaroxaban) inhibit coagulation activation and are used to prevent or treat thrombosis.
- Thrombolytics (e.g., alteplase) dissolve existing blood clots and are used in acute emergencies such as pulmonary embolism or stroke.
- Clotting factor concentrates are administered in cases of inherited clotting deficiencies such as haemophilia.
- Platelet transfusions may be required in cases of severe thrombocytopenia (low platelet count).
References
- Pschyrembel Clinical Dictionary. 268th Edition. De Gruyter, Berlin 2020.
- Levi M, van der Poll T. Coagulation and sepsis. Thrombosis Research. 2017;149:38-44. PubMed PMID: 28040521.
- World Health Organization (WHO). Inherited bleeding disorders. Available at: https://www.who.int (accessed 2024).
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryExtrauterine
Lactate Dehydrogenase Elevation
Uridine Biosynthesis Markers
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Coagulation Activation + Coagulation Activation + Blood Coagulation Activation